Risk Of Meningitis Following Posterior Fossa Decompression With Duraplasty In Cases Of Chiari Malformation Type 1 And Syringomyelia
Keywords:
Chiari malformation type I, syringomyelia, posterior fossa decompression, duraplasty, meningitisAbstract
Objectives:
- To determine the risk of postoperative meningitis following posterior fossa decompression with duraplasty in patients with Chiari malformation type 1 and syringomyelia.
- To determine the incidence of other postoperative complications: pseudo meningocele, CSF leak and the need for reoperation following the surgery.
- To evaluate the association of demographic, clinical, and surgical factors, including graft type, with the occurrence of meningitis and other postoperative complications.
Methodology:
This prospective descriptive cohort study was conducted from January 2024 to January 2025 at a tertiary care center. A total of 60 patients aged 10–65 years undergoing PFDD were included through consecutive sampling. Patients were followed at 1, 3, 6, and 12 months postoperatively. The primary outcome was meningitis, defined by CSF pleocytosis with microbiological confirmation. Secondary outcomes included pseudo meningocele, cerebrospinal fluid (CSF) leak, and reoperation. Associations between demographic, clinical, and surgical variables, including graft type, were analyzed.
Results:
The mean age was 38.72 ± 16.41 years, with a female predominance (75%). The incidence of postoperative meningitis was 5%. Pseudo meningocele occurred in 8.3% of patients, while CSF leak and reoperation were observed in 5% each. Patients receiving non-autologous grafts demonstrated a higher relative risk of meningitis (RR = 3.29) and other complications; however, no statistically significant associations were found (p > 0.05).
Conclusion:
PFDD is associated with a measurable risk of postoperative complications, including meningitis, pseudo meningocele, and CSF leak. Although non-autologous grafts showed a higher relative risk, no significant predictors were identified. Larger multicenter studies are required to better define risk factors and optimize surgical outcomes
Downloads
References
1. Abd-El-Barr MM, Strong CI, Groff MW. Chiari malformations: diagnosis, treatments, and failures. J Neurosurg Sci. 2014;58(4):215-21.
2. Muzumdar D. Chiari 1 malformation: Revisited. J Pediatr Neurosci. 2019;14(4):179.
3. Frič R, Eide PK. Chiari type 1-a malformation or a syndrome? A critical review. Acta Neurochir. 2020;162(7):1513-25.
4. Cools MJ, Wellons JC, Iskandar BJ. The Nomenclature of Chiari Malformations. Neurosurg Clin N Am. 2023;34(1):1-7.
5. Roy AK, Slimack NP, Ganju A. Idiopathic syringomyelia: retrospective case series, comprehensive review, and update on management. Neurosurg Focus. 2011;31(6):15.
6. Klekamp J, Batzdorf U, Samii M, Bothe HW. Treatment of syringomyelia associated with arachnoid scarring caused by arachnoiditis or trauma. J Neurosurg. 1997;86(2):233-40.
7. Zuev AA, Kostenko GV. [Treatment of syringomyelia associated with Chiari 1 malformation]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(3):102-106.
8. Greitz D. Unraveling the riddle of syringomyelia. Neurosurg Rev. 2006;29(4):251-63.
9. Roser F, Ebner FH, Sixt C, Hagen JM, Tatagiba MS. Defining the line between hydromyelia and syringomyelia. A differentiation is possible based on electrophysiological and magnetic resonance imaging studies. Acta Neurochir. 2010;152(2):213-9
10. Arnautovic A, Splavski B, Boop FA, Arnautovic KI. Pediatric and adult Chiari malformation Type I surgical series 1965-2013: a review of demographics, operative treatment, and outcomes. J Neurosurg Pediatr. 2015;15(2):161-77.
11. Rahman A, Ahmed N, Abu Obaida AS, Uddin AN. A Novel Technique to Assess the Outcome of Adult Chiari Malformation 1 Radiologically Following Stealth Cranioplasty, Posterior Fossa Decompression, and Posterior Fossa. Decompression with Duraplasty. J Surg. 2023; 8:1868.
12. Aslan A, Rakip U, Boyacı MG, Yildizhan S, Kormaz S, Atay E, Coban N. Posterior Fossa Decompression and superficial durotomy rather than complete durotomy and duraplasty in the management of Chiari 1. Neurol Res. 2021;43(6):440-6.
13. Yahanda AT, Limbrick DD. Posterior Fossa Decompression with or Without Duraplasty for Chiari I Malformation. Neurosurg Clin N Am. 2023 Jan;34(1):105–11. doi:10.1016/j.nec.2022.08.008 PubMed PMID: 36424050.
14. Yamazaki D, Kobayashi M, Hirata S, Terano N, Wakiya K, Fujimaki T. Natural dural defect of the posterior fossa dura as a risk factor for postoperative cerebrospinal fluid leakage. World Neurosurg. 2020;142: e229-32.
15. Perdomo-Pantoja A, Iyer RR. Decompression With or Without Duraplasty? Evidence for Neurosurgery. 2019.
16. Yahanda AT, Adelson PD, Akbari SHA, Albert GW, Aldana PR, Alden TD, et al. Dural augmentation approaches and complication rates after posterior fossa decompression for Chiari I malformation and syringomyelia: a Park-Reeves Syringomyelia Research Consortium study. J Neurosurg Pediatr. 2021;27(4):459-468.
17. Farber H, McDowell MM, Alhourani A, Agarwal N, Friedlander RM. Duraplasty Type as a Predictor of Meningitis and Shunting After Chiari I Decompression. World Neurosurg. 2018;118: e778-e783.
18. De Vlieger, J., Dejaegher, J. & Van Calenbergh, F. Posterior fossa decompression for Chiari malformation type I: clinical and radiological presentation, outcome and complications in a retrospective series of 105 procedures. Acta Neurol Belg 2019; 119: 245–252. https://doi.org/10.1007/s13760-019-01086-7.
19. Pan, D., Yang, K., Li, J., Wang, Z., Zhang, J., Zheng, N., Yuan, X., Yu, S., & Sui, H. A new concept and surgical approach for Chiari malformation type I based on the protection and strengthening of the myodural Bridge. Scientific Reports 2015; 15(1): 9445. https://doi.org/10.1038/s41598-025-92506-7.
20. Khan, M. I., Munir, A., Ullah, S., & Khan, S. A. Short-Term Outcomes of Posterior Fossa Decompression with or without Duraplasty for Chiari Malformation Type 1: Insights from a Tertiary Care Hospital. Journal of Aziz Fatimah Medical & Dental College 2024; 6(1): 42–47. https://doi.org/10.55279/jafmdc.v6i1.287.
21. Jbarah, O. F., Aburayya, B. I., Shatnawi, A. R., Alkhasoneh, M. A., Toubasi, A. A., Alharahsheh, S. M., Nukho, S. K., Nassar, A. S., & Jamous, M. A. Risk of meningitis after posterior fossa decompression with duraplasty using different graft types in patients with Chiari malformation type I and syringomyelia: a systematic review and meta-analysis. Neurosurgical Review 2022; 45(6): 3537–3550. https://doi.org/10.1007/s10143-022-01873-6.
22. Chai, Z., Xue, X., Fan, H., Sun, L., Cai, H., Ma, Y., Ma, C., & Zhou, R. Efficacy of Posterior Fossa Decompression with Duraplasty for Patients with Chiari Malformation Type I: A Systematic Review and Meta-Analysis. World Neurosurgery 2018; 113: 357-365.e1. https://doi.org/10.1016/j.wneu.2018.02.092.
23. Yahanda, A. T., Simon, L. E., & Limbrick, D. D. Outcomes for various dural graft materials after posterior fossa decompression with duraplasty for Chiari malformation type I: a systematic review and meta-analysis. Journal of Neurosurgery 2021; 135(5): 1356–1369. https://doi.org/10.3171/2020.9.jns202641.
24. Rehman L, Akbar H, Bokhari I, Babar A.K, Hashim A.S.M, Arain S.H. Posterior Fossa Decompression with Duraplasty in Chiari-1 Malformations. Journal of the College of Physicians and Surgeons Pakistan 2015; 25(4): 254-258.
25. Caffo M, Cardali SM, Caruso G, Fazzari E, Abbritti RV, Barresi V, Germanò A. Minimally invasive posterior fossa decompression with duraplasty in Chiari malformation type I with and without syringomyelia. Surg Neurol Int. 2019; 10:88.
26. Sacco D, Scott RM. Reoperation for Chiari malformations. Pediatr Neurosurg. 2003 Oct;39(4):171-8
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.